retatrutide expanded access program eli lilly Eli Lilly Reports Strong Late-Stage Results for Next-Generation Obesity Drug Retatrutide Drug retatrutide helps people lower

Prefilled pens dial to your dose and inject with a button press, which some patients find simpler

The GLP-1 receptor is a type of cell surface receptor that binds to GLP-1, triggering a signaling cascade that leads to various effects, including the stimulation of insulin secretion, the inhibition of gastric emptying, and the promotion of satiety

The glucagon receptor activation increases energy expenditure and promotes the breakdown of fat stores, particularly visceral fat that accumulates around organs

These individuals would fall into the contraindicated category regardless of which specific GLP-1 medication they considered

Readers wishing to verify the current scope of the TRIUMPH programme including whether a dedicated cardiovascular outcomes trial is registered are encouraged to consult the trial registries at ClinicalTrials.gov or the EU Clinical Trials Register (EudraCT)